Sherman Darren
Company insiders · See Remarks · Director · Orchestra BioMed Holdings, Inc.
- Reported transaction lines
- 1
- Buy lines
- 0
- Sell lines
- 1
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-111
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Sherman Darren See Remarks · Director · Orchestra BioMed Holdings, Inc. | OBIO Orchestra BioMed Holdings, Inc. | SellFiling detailsSEC transaction code S Common Stock, par value $0.0001 per share ("Common Stock") · Direct ownership · Reported balance after transaction: 1104402 · SEC code covers open-market or private transactions · The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025. · The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $5.66 to $5.995. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote. · President and Chief Operating Officer | 2026-11-02 | 2026-11-03 | ≈ $86,100.00 15,000 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.